110: Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E,
        Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE.

        Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated
        recombinant Japanese encephalitis virus - poxvirus vaccines in
        vaccinia-nonimmune and vaccinia-immune humans.
        Vaccine. 2000 Oct 15;19(4-5):483-491.

        [Production of purified Japanese encephalitis vaccine from Vero cells
        with roller bottles].
        Chung Hua I Hsueh Tsa Chih. 1998 Apr;78(4):261-2. Chinese.

        108: Tseng CY, Hwang KP, Lin KH, Chen HY, Lu CC, Chiang CH.

        Comparison of immunogenicity of simultaneous and nonsimultaneous
        vaccination with MMR and JE vaccine among 15-month-old children.
        Taiwan Erh Ko I Hsueh Hui Tsa Chih. 1999 May-Jun;40(3):161-5.

        107: Aihara H, Takasaki T, Toyosaki-Maeda T, Suzuki R, Okuno Y,
        Kurane I.

        T-cell activation and induction of antibodies and memory T cells by
        immunization with inactivated Japanese encephalitis vaccine.
        Viral Immunol. 2000;13(2):179-86.

        106: Kurane I, Takasaki T.

        Immunogenicity and protective efficacy of the current inactivated
        Japanese encephalitis vaccine against different Japanese encephalitis
        virus strains.
        Vaccine. 2000 May 26;18 Suppl 2:33-5. Review.

        105: Markoff L.

        Points to consider in the development of a surrogate for efficacy of
        novel Japanese encephalitis virus vaccines.
        Vaccine. 2000 May 26;18 Suppl 2:26-32. Review.

        104: Tsai TF.

        New initiatives for the control of Japanese encephalitis by vaccination:
        minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
        Vaccine. 2000 May 26;18 Suppl 2:1-25.

        103: Kumar R.

        Viral encephalitis of public health significance in India: current
        status.
        Indian J Pediatr. 1999 Jan-Feb;66(1):73-83.

        102: Broom AK, Wallace MJ, Mackenzie JS, Smith DW, Hall RA.

        Immunisation with gamma globulin to murray valley encephalitis virus and
        with an inactivated Japanese encephalitis virus vaccine as prophylaxis
        against australian encephalitis: evaluation in a mouse model.
        J Med Virol. 2000 Jun;61(2):259-65.

        101: Saito M, Sunagawa T, Makino Y, Tadano M, Hasegawa H, Kanemura
        K, Zamami Y, Killenbeck BJ, Fukunaga T.

        Three Japanese encephalitis cases in Okinawa, Japan, 1991.
        Southeast Asian J Trop Med Public Health. 1999 Jun;30(2):277-9.